|Horizon||30 Days Login to change|
Wize Pharma Total Value AnalysisWize Pharma is at this time anticipated to have takeover price of 35.93 M with market capitalization of 35.89 M, debt of 707 K, and cash on hands of 275 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Wize Pharma fundamentals before making investing decisions based on the enterprise value of the company
Wize Pharma Asset UtilizationWize Pharma maintains negative operation of resources of -80.74 (%), securing only S0.81 for each shekel of resources held by the organization. Inadequate assets utilization attests that the company is being less effective with each shekel of resources it maintains. Specifically assets utilization of Wize Pharma shows how discouraging it operates for each shekel spent on its resources.
Wize Pharma Profitability AnalysisThe company reported revenue of . Net Loss for the year was (1.91 M).